Nucleome is backed by a world-class syndicate of investors: M Ventures, the venture capital arm of Merck KGaA; Johnson and Johnson Innovation - JJDC, Inc. ("JJDC"); Pfizer Ventures; British Business ...

New data reveals differences in gene activity in the brains of men and women. They start in the womb and evolved millions of ...

Harvard University scientists have developed the first menstruating mice. This breakthrough allows for new research into ...

We elucidated that DNA methyltransferase 1 (Dnmt1), an epigenetic regulator, properly controls bone elongation by modulating energy metabolism in ...

On November 6, 2025, Shanghai, China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology ...

A study conducted by a multinational research group investigated the potential of audible sound waves (in the form of music, specifically Pink Floyd’s "Another Brick in the Wall, Part 1") in enhancing ...

Qiagen has identified Parse Biosciences’ technology as complementary to its sample technology and bioinformatic businesses.

University of Michigan researchers discovered that touch can suppress a longevity gene called fmo-2 in worms, reducing the ...

The data shows that downregulating PU.1 promotes the expression of immunoregulatory proteins on microglia that help protect cognitive function.

The pursuit of a longer life may currently be trending for tech bros, but the notion of a fountain of youth, or even ...

Felzartamab, an investigational anti-CD38 monoclonal antibody, is a potentially differentiated therapeutic candidate with promise for a broad range of immune-mediated diseases ...